> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Armenpharm ANDA Withdrawn for Safety/Effectiveness
- URL: https://www.fdaweb.com/armenpharm-anda-withdrawn-for-safety-effectiveness/
- Published: 2016-09-21T12:00:00.000Z
- Updated: 2026-09-14T21:33:51.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5136870

*Federal Register* Notice: FDA is suspending approval of an Armenpharm, Ltd. ANDA for chloramphenicol capsules, 250 mg because previous versions of chloramphenicol were withdrawn from sale for reasons of safety or effectiveness. The agency says it will not accept or approve ANDAs for chloramphenicol capsules, 50 mg and 100 mg, or chloramphenicol palmitate oral suspension, 150 mg/5 mL. To view this notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2016-09-21/pdf/2016-22660.pdf?ref=fdaweb.com).